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The clinical value of imaging modalities (USG, EUS, CT) 
in pancreatic carcinoma staging
Jan Kulig, Tadeusz Popiela, Aleksander Zając, Stanisław Klęk, Piotr Kołodziejczyk
A  i m. to assess the clinical value o f endoscopic ultrasound in the staging o f  pancreatic carcinoma as opposed to 
ultrasonography and CT.
M a t e r i a l  a n d  m e t h o d s .  We evaluated 42 patients (18 F, 24 M; mean age 61.3) operated on for pancreatic carcinoma 
between 1991 and 2002 analysing accuracy, sensitivity, specificity, PPV and N P V  o f routine and doppler ultrasonography, CT  
and EUS.
R e s u l t s .  EUS showed the best accuracy in local tumour staging -  93.1%, vascular infiltration -  90%, and lymph node 
assessment -  87.5%. Routine USG was the least accurate: 82.5%, 67.5% and 72.5%, respectively. The accuracy o f both CT  
and doppler USG were similar: 88.1%, 82.5% and 80.0%.
C o n c l u s i o n s .  EUS is the most accurate method available to stage pancreatic cancer in the pre-operative period. However, 
the advantage o f EUS as opposed to C T and USG does not justify its routine use due to the costs, its low availability and 
invasiveness.
Wartość kliniczna badań obrazowych (USG, EUS, KT) 
w ocenie zaawansowania raka trzustki
C el pracy .  Ocean wartości klinicznej ultrasonografii endoskopowej w ocenie zaawansowania raka trzustki jako metody 
konkurencyjnej dla USG i tomografii komputerowej.
M a t e r i a ł  i m e to d y .  Badaniu poddano 42 chorych (18 K, 24 M), średni wiek: 61,3) operowanych z  powodu raka 
trzustki w latach 1991-2002. Przeanalizowano trafność diagnostyczną, czułość, swoistość, PPV i N P V  USG tradycyjnego, 
doplerowskiego, K T  i EUS.
Wy n ik i .  Najwyższą dokładność w ocenie zaawansowania miejscowego, naciekania naczyń krwionośnych oraz przerzutów 
do węzłów wykazała EUS -  odpowiednio 93,1%, 90%, 87,5%. Najmniejszą trafność wykazało rutynowe badanie USG: 
odpowiednio 82,5%, 67,5% i 72,5%. Trafność K T  i doplerowskiego USG była zbliżona: 88,1%, 82,5% oraz 80,0%. 
W n i o s k i .  Najbardziej precyzyjną metodą w przedoperacyjnej ocenie miejscowego zaawansowania raka trzustki jest 
endoskopowa ultrasonografia. Wydaje się jednak, że z  powodu kosztu, małej dostępności i inwazyjności nie może ona 
zastąpić w rutynowej diagnostyce raka trzustki metod ultrasonograficznych i tomografii komputerowej.
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Introduction
Pancreatic cancer is one of the leading causes of death in 
the USA. Mortality rates place this neoplasm fourth as far 
as morbidity is concerned [1, 2]. Prognosis is very poor, 
with the one-year mortality rate exceeding 80% and the 
overall 5-year survival rates not exceeding 5%. Detection 
of early pancreatic cancer is of great importance because 
this type of carcinoma is potentially resectable. However,
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early detection is extremely difficult due to the scarcity of 
symptoms.
The choice of treatm ent in pancreatic cancer de­
pends mostly on correct diagnosis and staging. Accurate 
diagnosis enables the most appropriate method of surgical 
and multim odal treatm ent and avoids unnecessary 
laparotomy (which in advanced disease does not improve 
survival nor quality of life and exposes patients to 
increased suffering at the same time generating high 
treatm ent costs).
Endoscopy, computed tomography, M RI and ultra­
sonography are the most common methods used to today 
in order to evaluate pancreatic carcinoma. Computed
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tomography, considered to be the "gold standard" in many 
countries, achieves a 95% accuracy in detecting and 
staging pancreatic carcinoma. Routine ultrasonographic 
techniques are slightly less efficient, with an accuracy 
ranging from 67% to 85% [3-5]. Some authors report 
that Doppler imaging can improve those results, even up 
to 95% [3, 6, 7].
EUS is an imaging technique, which combines both 
endoscopy and ultrasonography, and thus possesses 
advantages of both m odalities (exclusion of acoustic 
barriers and higher picture resolution). It is thought that 
EUS is one of the best methods for detecting small, early 
pancreatic neoplasm [8-10].
The aim of the study was to assess the clinical value 
of endoscopic ultrasound in detecting and staging 
pancreatic carcinoma compared to more routine imaging 
methods.
Material and methods
The study was designed as a retrospective clinical trial involving 
42 patients (18 women and 24 men; mean age 61.3; range 37-81 
years) operated on for pancreatic tum our (with suspicion of 
carcinoma) at the 1st D epartm ent of General and GI Surgery, 
Jagiellonian University of Cracow, between January 1991 and 
December 2002. All subjects gave informed consent.
Using routine color and power D oppler ultrasonography, 
helical computed tomography and EUS, multiple analyses of 
diagnostic accuracy, sensitivity, specificity, and positive as well as 
negative prognostic values (PPV and NPV) were made. The 
stage of the cancer was consistently classified using WHO TNM 
classification. Siemens Sonoline AC and Hitachi EUB 555 and 
6000. Ultrasonographic equipment was used to perform ultra­
sound examinations. Helical, dual-scan computed tomography 
was performed using Elscint and Siemens Sommatom Sensation 
10 approx. three hours after the administration of oral contrast 
(1000 ml 2.0% U rographin, Schering AG) and additional 
administration of intravenous contrast (Uropolinum or Omi- 
paque, Polpharm a and Nycomed, respectively). Endoscopic 
ultrasound examinations were made using Pentax FG-38UX 
and Olympus EXU-M3 with Siemens Sonoline AC and Hitachi 
EUB 555 and 6000. Examinations were performed in the lateral 
position, after infusion of pharm aceutical pre-m edication 
(Dolargan and Buscolisinum i.v.). All results were collected as 
prints, *.jpeg, *.tiff files (MO and HD).
All examinations were performed according to the same 
protocol, which included the evaluation of pancreatic neoplasm, 
its local and regional staging, as well as the assessment of all 
other abdominal organs, in order to determine the presence of 
dissemination and distant metastases. To verify the accuracy of 
diagnostic imaging, the following methods were used:
-  intraoperative surgeon’s evaluation,
-  histopathological examination of the tum or and specimens,
-  intraoperative ultrasound findings.
Statistical evaluation was perform ed using Statistica™  
software. Student's T test was used to determ ine significant 
differences.
Results
The study included 42 patients, 27 of which underwent 
pancreatic resection (11 Kausch-Whipple procedures, 
9 pylorus-preserving resections, 4 total pancreatectomies, 
and 3 distal resections). Only 15 palliative procedures 
(due to unresectable cancer) were performed.
In 37 of 42 patients who underw ent surgery, the 
diagnosis of pancreatic ductal carcinoma was made. In 3 
patients, endocrine neoplasm (insulinoma) was found 
and in 2 patients -  non-cancerous lesions (chronic 
pancreatitis) were diagnosed. The most common, local 
stage of cancer according to the TNM classification was 
T4, found in 11 patients (29.7%). Less frequent stages 
w ere T2 and T3, found in 10 patients (27.0%) and 9 
patients (24.3%), respectively. The least common stage 
diagnosed was early carcinoma, T1, detected in 7 patients 
(18.9%). Complete analysis of diagnostic accuracy of 
EUS, CT and ultrasonographic methods was carried out 
in 37 patients with pancreatic ductal adenocarcinoma; 
the other cases (endocrine and non-carcinom atous 
tumours) were omitted from study.
Although full statistical analysis was not possible in 
the group with T1 stage cancer, due to small group size 
(n= 7), it is worth m entioning that the most accurate 
modality to assess early cancer was EUS (6 correct 
diagnoses and 1 false negative). There were 4 false 
negative results with routine USG and 3 false negatives 
with CT and doppler-USG combined. Detailed data is 
shown in Table I.
Table I. Overall accuracy of ultrasonographic modalities, EUS and CT 
in local staging of pancreatic cancer (n=37)
Routine
USG
NS/S Doppler 
USG
NS/S EUS NS/S CT
T1 (n=7)
Correct diagnosis 3/7 4/7 6/7 4/7
T2 (n=10) 
Accuracy 77.5 S 85.0 S 92.5 S 85.0
T3 (n=9) 
Accuracy 77.5 S 85.0 S 90.0 S 85.0
T4 (n=11) 
Accuracy 85.0 S 90.0 S 92.5 S 90.0
Statistical analyses of T2-T4 stages were made 
separately with a combined T1-T4 stage analysis. The 
most accurate assessment of T2 stage was made with EUS 
(overall accuracy 92.5%), and the sensitivity, specificity, 
PPV and NPV are all presented together with the 
parameters of the other methods in Table I. The accuracy 
of routine ultrasound, Doppler ultrasound and CT were 
77.5% and 85.0%, respectively.
EUS was also determ ined to be the best m ethod 
used to assess T3 and T4 stages (90.0% and 92.5%, 
respectively). The difference between EUS and the other 
imaging tests used was significant (p<0.05). Routine USG 
used to assess stages T3 and T4 achieved accuracy scores 
of only 77.5% and 85.0%, respectively; but both doppler- 
USG and CT improved the results to 85.0% and 90.0% 
accuracy, respectively [Figures 1-4].
General analysis of local advancement of pancreatic 
carcinoma (stages T1 -  T4) proved that EUS was the 
most efficient m ethod, with a diagnostic accuracy of
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Figure 1. Pancreatic cancer -  EUS
Figure 2. Pancreatic cancer -  EUS + D oppler technique -  no signs of 
vessel infiltration
Figure 3. Advanced pancreatic cancer (T 4) -  EUS
Figure 4. Pancreatic cancer: USG -  color-Doppler -  no infiltration of 
large vessels
93.1% and a sensitivity, specificity, PPV and NPV of 
82.5%, 96.6%, 89.1% and 95.1%, respectively. These 
results were significantly better than the other methods, 
all of which are shown in Table I.
The evaluation of ultrasound and CT techniques to 
assess vascular carcinomatous infiltration was the next 
aim of the study. Such data is essential when planning 
surgery. Each ultrasound and CT exam included the
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Figure 5. Pancreatic cancer: USG -  power-Doppler -  infiltration of the 
portal vein
evaluation of the following vessels: the superior mesen­
teric vein and artery, the portal vein, the inferior vena 
cava, the aorta and the celiac trunk [Figures 5, 6].
Routine ultrasound procedure achieved a relatively 
low accuracy of 67.5% (sensitivity: 74.0%, specificity: 
53.8%, PPV: 76.9% and NPV: 53.8%) and color-doppler 
imaging improved the accuracy up to 82.5% (sensitivity, 
specificity, PPV and NPV 88.8%, 69.2%, 85.7% and
VC
Figure 6. Pancreatic cancer -  EUS + D oppler technique -  portal vein 
infiltration
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75.0%, respectively). The same results were obtained with 
CT. EUS was the most accurate method with an overall 
rate 90.0%, and sensitivity, specificity, PPV and NPV of 
96.1%, 84.6%, 92.0%, and 84.6%, respectively. These 
results were significantly higher than the other obtained.
The presence of nodal spread of pancreatic carci­
noma is very valuable information from the surgeons’ 
point of view, as it is always associated with a poor 
prognosis. In this study the accuracy of imaging methods 
was evaluated in a group of 40 patients (only the patients 
who underwent resection were enrolled). Histopatho- 
logical examinations showed the incidence of nodal 
metastases to be 16 (40%).
The study showed that EUS is the most precise 
diagnostic tool to determine lymph node metastases; EUS 
accuracy reached 87.5%, while the efficacy of routine 
ultrasound was 72.5%, ultrasound with doppler technique 
80.0% and CT 82.5%. The differences were significant 
(p<0.05).
Discussion
Modern approach to pancreatic cancer treatment requires 
individual strategy and is mostly depended on diagnostic 
tools, as correct diagnosis and staging determine further 
tactics. Although endoscopy, computed tomography, MRI 
and ultrasound are most often used to evaluate pancreatic 
carcinoma, there is still a need to find the most optimal 
diagnostic method for its staging.
Correct assessment of early pancreatic carcinoma 
(T1 stage according to W HO) proves most valuable in 
pre-operative diagnosis. Innocenti et al. and Pichler et 
al. have reported  that the accuracy of routine u ltra­
sonography in T1 evaluation does not exceed 67.0% -  
72.3%, and Doppler technique increases it to 87.4% [11, 
12]. The accuracy of CT, according to Freeny et al., Gress 
et al. and Legman et al., reaches 67.0% [13-15]. Rosch et 
al. and Shoup et al. showed accuracy of 90.0% -  99.0% in 
early pancreatic cancer staging with EUS, documenting its 
value in detecting endocrine tum ors smaller than 15 
millimeters in diameter [15, 16]. The same high efficacy 
was observed in advanced stages: Mertz et al., Rosch et al. 
and Shoup et al. reported an accuracy of 93.0% -  100% in 
stages T2 -  T4 [15-17].
The efficiency of imaging m ethods in advanced 
cancer stages is far better than in other methods; 
according to Pichler et al. and Howard et al., the accuracy 
of routine ultrasound at stages T2 -  T4 was 85.0% -  
90.0%, while Doppler technique increased it to 91.2% 
[12, 18]. At the same stage, CT showed an efficacy of 
95.0%, reported by Bluemke, Calculli, Legman and Rosch 
et al. This opinion was, however, questioned by Chen et 
al. and Gorelick et al [3, 5, 15, 19, 20, 21].
Our research confirmed that EUS plays a leading 
role in local staging assessment. In the early stage, we 
observed only one false negative result out of seven cases. 
Accuracy of 92.5%, 90.0 and 92.5% was observed in 
stages T2, T3 and T4, respectively. The efficiency of 
routine and Doppler ultrasound and CT was poorer.
The presence of large vessel involvement caused by 
pancreatic cancer is important information when planning 
surgery. The efficiency of routine ultrasound for deter­
mining local vascular invasion is variable and can be poor. 
A  majority of authors judge it to be about 60.0% [1, 8]. 
M odern ultrasound techniques improve the accuracy, 
increasing it to even 84.0% -  96.0% [6, 22, 23]. According 
to Calculli et al., Legman et al. and Ueno et al., CT is 
considered to be of similar effectiveness, reaching up to 
100%, while others report values higher than 80.0% to be 
unlikely [3, 5, 14, 20, 22, 24].
Opinions vary as to the accuracy of EUS; Baarir et 
al. have shown it to be 95.0 % - 96.0%, but Howard et 
al. have questioned these outcomes, reporting the 
accuracy to be 76.0% [18, 25].
In our study the accuracy of routine ultrasound was 
67.5%. 82.5% accuracy was achieved with Doppler- 
ultrasound and computed tomography combined. EUS 
was the best method to evaluate vascular involvement, 
with a correct diagnosis in 90.0% of cases. Our research 
concurred with the majority of reports regarding EUS, 
however, the accuracy of CT was lower than that reported 
by Calculli, Legman and Ueno [3, 5, 23].
The evaluation of nodal spread, which is an im ­
portant prognostic factor, is one of the most difficult tasks 
to assess. Gorelick et al. and Pichler et al. have reported 
routine ultrasound to have an accuracy of 76.6% -  78.3%, 
but Chen et al. have questioned this opinion, because in 
their study sensitivity did not exceed 33% [12, 20, 21]. 
Both Bunk et al. and Innocenti et al. indicate that 
Doppler techniques can improve the efficacy, increasing it 
to 82.5% [11, 22]. CT, which is thought to be the ”gold 
standard” in local assessment of pancreatic cancer, is also 
helpful in nodal status evaluation. Chen et al., Grees et 
al., Legman et al., van Hoe et al. and Tomazic et al. 
demonstrated its accuracy to be 50.0% -  85.0% with CT, 
which was not confirmed by Chen et al. and Yeo et al. 
(accuracy of 50.0%) [5, 7, 20, 26, 27]. The efficiency of 
EUS is also variable; Howard et al., and Gress et al. 
observed an accuracy of 72.0% -  75.0%, while Chen et al., 
and Yeo et al. reported only 47.0% -  62.0% [14, 18, 20, 
27].
Our results have confirm ed the relatively low 
accuracy of routine ultrasonography (72.5%), doppler- 
ultrasonography (80.0%) and CT (82.5%). Again, EUS 
proved to be the most efficient, with an accuracy 
exceeding 87.0%.
Our study dem onstrated that endoscopic u ltra­
sonography is the most accurate method of assessing not 
only local tumor stage, but also vascular and nodal status. 
The efficiency of EUS was the highest in all categories, 
but only in the case of early carcinoma did the difference 
achieve statistical significance. In the other categories 
this difference was not so obvious. Thus EUS is an 
expensive, invasive technique with a low availability and 
creating the possible need to re-examine the patient. 
Therefore, it should not be the routine method of choice 
in each case, but should be used only when the diagnostic 
problems cannot be solved with ultrasound or CT.
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Conclusions
1. EUS is the best method to diagnose early pancreatic 
cancer (6 out of 7 patients); the same diagnosis was 
made in only 3 and 4 of these same 7 cases when USG 
or CT were used, respectively.
2. The general local staging accuracy of EUS exceeded 
93.1%, routine ultrasound reached 82.5%, and 
Doppler USG and CT reached 88.1%.
3. The accuracy of vascular involvement detection was 
67.5% with routine USG, 82.5% with CT and Doppler 
USG, and 90.0% with EUS.
4. The accuracy of EUS is also the highest in lymph node 
assessment (87.5%).
5. Endoscopic ultrasonography is the most accurate 
method to diagnose and stage pancreatic carcinoma 
in the pre-operative period.
6. EUS is invasive, expensive and of limited availability as 
compared to routine or Doppler USG; therefore, it 
should be used in selected cases, especially when early 
pancreatic carcinoma is suspected.
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